Physician perspectives of Helicobacter pylori diagnostic and treatment practices in Canada: results of a Canadian survey

BMC Gastroenterol. 2024 Jun 17;24(1):204. doi: 10.1186/s12876-024-03293-w.

Abstract

Background: Helicobacter pylori infection is prevalent worldwide and can lead to peptic ulcer disease (PUD) and gastric cancer. Effective diagnosis and treatment of H. pylori infection by gastroenterologists and family physicians is crucial. However, there are differing views on optimal diagnosis and treatment. The objective of this study is to understand the impressions of Canadian physicians regarding H. pylori diagnosis and treatment and whether impressions differ between gastroenterologists and family physicians. A second objective is to understand physician perspectives on rising antibiotic resistance and how that guides empiric management.

Methods: A survey facilitated via REDCap was administered to Canadian gastroenterologists and family physicians. A total of 105 participants completed the survey, including 43 gastroenterologists and 62 family physicians. Gastroenterologists were recruited from across the country and family physicians were recruited from Manitoba.

Results: For diagnosis of H. pylori, 67% of gastroenterologists reported endoscopic biopsies for histology assessment as most common and 73% of family physicians reported serology as their main diagnostic test. While nearly all gastroenterologists believed antibiotic resistance to be a problem, nearly one quarter of family physicians did not believe it was a problem.

Conclusions: There is variability in practices among both gastroenterologists and family physicians regarding diagnosis of H. pylori infection. There was consensus that local antibiotic resistance patterns should guide management. If known, the degree and patterns of antibiotic resistance could bring a more uniform consensus to H. pylori management. Greater education of physicians, especially family physicians regarding management of H pylori is needed.

Keywords: Antibiotic resistance; Helicobacter pylori; Peptic ulcer disease.

MeSH terms

  • Adult
  • Anti-Bacterial Agents* / therapeutic use
  • Attitude of Health Personnel
  • Biopsy / statistics & numerical data
  • Canada
  • Drug Resistance, Bacterial
  • Female
  • Gastroenterologists
  • Helicobacter Infections* / diagnosis
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori*
  • Humans
  • Male
  • Middle Aged
  • Physicians, Family / statistics & numerical data
  • Practice Patterns, Physicians'* / statistics & numerical data
  • Surveys and Questionnaires

Substances

  • Anti-Bacterial Agents